Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Aberg

Showing results (21-30 of 211) with videos related to

Pageof 22
Sort By:
Clinical Lipidology|January 5, 2012
Management of dyslipidemia in HIV-infected patientsCarlos D Malvestutto, Judith A Aberg
JAMA|May 23, 2013
Care for transgender personsAnn Danoff, Demetre Daskalakis, Judith A Aberg
Expert Review of Anti-Infective Therapy|November 28, 2007
Pafuramidine for Pneumocystis jiroveci pneumonia in HIV-infected individualsDonald Chen, Rebecca Marsh, Judith A Aberg
Lancet (London, England)|May 17, 2021
Convalescent plasma in patients hospitalised with COVID-19Sean T H Liu, Judith A Aberg
Journal of Acquired Immune Deficiency Syndromes (1999)|January 2, 2007
Discontinuation of antiretroviral therapy postpartum: no evidence for altered viral set pointMarisa Tungsiripat, Henning Drechsler, Judith A Aberg
Journal of Clinical Pharmacology|February 5, 2015
Management of lipid disorders in patients living with HIVMerle Myerson, Carlos Malvestutto, Judith A Aberg
HIV Clinical Trials|June 20, 2003
Tolerance of efavirenz-induced central nervous system side effects in HIV-infected individuals with a history of substance abuseSalomé N Juethner, Warren Seyfried, Judith A Aberg
Seminars in Diagnostic Pathology|May 30, 2017
Aging with HIV in the ART eraEmma Kaplan-Lewis, Judith A Aberg, Mikyung Lee
Current HIV/AIDS Reports|August 27, 2016
Atherosclerotic Cardiovascular Disease and Anti-Retroviral TherapyEmma Kaplan-Lewis, Judith A Aberg, Mikyung Lee
HIV Clinical Trials|April 17, 2007
Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087Scott R Evans, Carl J Fichtenbaum, Judith A Aberg, et al.
Pageof 22

Showing results (21-30 of 211) with videos related to

Sort By:
Pageof 22
Clinical Lipidology|January 5, 2012
Management of dyslipidemia in HIV-infected patientsCarlos D Malvestutto, Judith A Aberg
JAMA|May 23, 2013
Care for transgender personsAnn Danoff, Demetre Daskalakis, Judith A Aberg
Expert Review of Anti-Infective Therapy|November 28, 2007
Pafuramidine for Pneumocystis jiroveci pneumonia in HIV-infected individualsDonald Chen, Rebecca Marsh, Judith A Aberg
Lancet (London, England)|May 17, 2021
Convalescent plasma in patients hospitalised with COVID-19Sean T H Liu, Judith A Aberg
Journal of Acquired Immune Deficiency Syndromes (1999)|January 2, 2007
Discontinuation of antiretroviral therapy postpartum: no evidence for altered viral set pointMarisa Tungsiripat, Henning Drechsler, Judith A Aberg
Journal of Clinical Pharmacology|February 5, 2015
Management of lipid disorders in patients living with HIVMerle Myerson, Carlos Malvestutto, Judith A Aberg
HIV Clinical Trials|June 20, 2003
Tolerance of efavirenz-induced central nervous system side effects in HIV-infected individuals with a history of substance abuseSalomé N Juethner, Warren Seyfried, Judith A Aberg
Seminars in Diagnostic Pathology|May 30, 2017
Aging with HIV in the ART eraEmma Kaplan-Lewis, Judith A Aberg, Mikyung Lee
Current HIV/AIDS Reports|August 27, 2016
Atherosclerotic Cardiovascular Disease and Anti-Retroviral TherapyEmma Kaplan-Lewis, Judith A Aberg, Mikyung Lee
HIV Clinical Trials|April 17, 2007
Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087Scott R Evans, Carl J Fichtenbaum, Judith A Aberg, et al.
Pageof 22